Valencia Technologies, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Valencia Technologies, Inc. - overview

Established

2011

Location

Valencia, CA, US

Primary Industry

Medical Devices & Equipment

About

Based in California, US, and founded in 2011 by Jeff Greiner, Valencia Technologies, Inc. operates as operates as a provider of implantable neuromodulation devices intended for bladder control therapy to patients experiencing urge urinary incontinence (UUI). In January 2026, Boston Scientific Corporation agreed to acquire Valencia Technologies, Inc. from Blackbrook Management Group.


Financial terms were not disclosed. The transaction is expected to be completed in June 2026, subject to customary closing conditions pending regulatory review. The company provides a wide range of neuromodulation products such as eCoin, an implantable tibial neurostimulator for urge urinary incontinence. The device delivers automatic tibial nerve stimulation and is implanted through a minimally invasive procedure using local anesthesia.


Additionally, the firm also provides support services for device management and clinical assistance. The January 2026 acquisition will enable Boston Scientific Corporation to enter the implantable tibial nerve stimulation market and increase the range of therapies offered in its urology division.


Primary Industry

Medical Devices & Equipment

Sub Industries

Therapeutic Devices

Website

https://valenciatechnologies.com/

Verticals

Manufacturing

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.